MannKind | MNKD - Passività Correnti





Passività Correnti Cambiamento Data
Adma Biologics USD 75.76M 2.22M 2026-06
BioCryst Pharmaceuticals USD 208.85M 13.46M 2026-06
Eli Lilly USD 47.74B 11.11B 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
MacroGenics USD 108.82M 12.88M 2026-06
MannKind USD 142.9M 8.34M 2026-06
Merck USD 27.73B 786M 2026-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Novavax USD 330.57M 11.89M 2026-06
Novo Nordisk DKK 36.54B 188.62B 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Xencor USD 81.86M 8.41M 2026-06